Yashica Pharmaceuticals Private Limited, a active private limited company, was established on 15 November 2007 in Kalyan West, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230MH2007PTC175913. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sanjay Khandu Totare (Director), Vaishali Sanjay Totare (Director). It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 101, Lalji Arcade, B Wing, Opp. Saibaba Mandir, Santoshi Mata Mandir Road,, Kalyan West, Maharashtra, 421301.
U24230MH2007PTC175913
175913
15 November 2007
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Yashica Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Khandu Totare | Director | 15 Nov 2007 | Current |
| Vaishali Sanjay Totare | Director | 15 Nov 2007 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Yashica Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 104.64% increase. The company also saw a substantial improvement in profitability, with a 246.73% increase in profit. The company's net worth Soared by an impressive increase of 10.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Yashica Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2023 | Axis Bank Limited | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Yashica Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Yashica Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yashica Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Yashica Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Yashica Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge with Axis Bank Limited amounted to Rs. 20.00 M with Charge ID 100687665 was registered on 01 Feb 2023. was completed.
Progress on Sanjay Khandu Totare was appointed as a Director was appointed as a Director on 15 Nov 2007 & has been associated with this company since 18 years 15 days . was documented.
The activity Vaishali Sanjay Totare was appointed as a Director was appointed as a Director on 15 Nov 2007 & has been associated with this company since 18 years 15 days . was completed.
Progress on Yashica Pharmaceuticals Private Limited was registered on 15 Nov 2007 with Roc Mumbai & aged 18 years 15 days as per MCA records. was documented.
The CIN of Yashica Pharmaceuticals Private Limited is U24230MH2007PTC175913.
Yashica Pharmaceuticals Private Limited is headquartered at 101, Lalji Arcade, B Wing, Opp. Saibaba Mandir, Santoshi Mata Mandir Road,, Kalyan West, Maharashtra, 421301.
Yashica Pharmaceuticals Private Limited was incorporated on 15 November 2007.
The current directors of Yashica Pharmaceuticals Private Limited are
The primary industry of Yashica Pharmaceuticals Private Limited is Trade.
Yashica Pharmaceuticals Private Limited is unlisted.
The authorized capital of Yashica Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Yashica Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX